• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF-α-308 多态性决定汉族强直性脊柱炎的临床表现和治疗反应。

TNF-α-308 polymorphism determines clinical manifestations and therapeutic response of ankylosing spondylitis in Han Chinese.

机构信息

Medical School of Nanjing University, Nanjing 210093, China; Department of Internal Medicine, the First Affiliated Hospital, Xinxiang Medical University, Weihui 453100, China.

Department of Internal Medicine, the First Affiliated Hospital, Xinxiang Medical University, Weihui 453100, China.

出版信息

Med Clin (Barc). 2017 Dec 20;149(12):517-522. doi: 10.1016/j.medcli.2017.04.023. Epub 2017 Jun 11.

DOI:10.1016/j.medcli.2017.04.023
PMID:28610765
Abstract

BACKGROUND AND OBJECTIVE

There is ongoing debate as to whether tumor necrosis factor alpha (TNF-α)-308 is associated with ankylosing spondylitis (AS). The aim of the present study was to determine whether TNF-α-308 is involved into genetic susceptibility, clinical features and therapeutic response of AS in Han Chinese.

METHODS

Two hundred and sixty AS patients with 260 ethnically matched healthy blood donors were enrolled into the present study. TNF-α-308 promoter polymorphism was identified using polymerase chain reaction amplification with restriction fragment length polymorphism assay.

RESULTS

Population genetic analysis showed that the prevalence of allele A and G/A genotype was equally infrequent in both AS patients (3.85% and 7.69%) and healthy subjects (4.23% and 8.46%). Compared with the carriers of G/G genotype, remarkably elevated erythrocyte sedimentation rate and serum C-reactive protein were observed in AS patients with G/A variant (87.06±49.40 vs. 55.53±42.99mm/h, P=.0126; 54.95±27.77 vs. 34.36±36.13mg/dl, P=.0116, respectively), and they always presented with inflammatory spinal pain (70.00% vs. 43.33%, P=0.0214) and suffered relatively mild sacroiliitis (65.00% vs. 41.67%, P=0.0431). The allele G and G/G genotype were more frequent in good responders to anti-TNF-α treatment (96.55% vs. 73.53%, P=.0032; 93.10% vs. 47.06%, P=.0015), whereas there was no obvious superiority of them in predicting therapeutic response of conventional medications for AS.

CONCLUSIONS

Our data suggest that TNF-α-308 polymorphism may influence the clinical features rather than susceptibility to AS in our Han Chinese.

摘要

背景和目的

肿瘤坏死因子-α(TNF-α)-308 与强直性脊柱炎(AS)之间是否存在关联仍存在争议。本研究旨在确定 TNF-α-308 是否参与汉族人群 AS 的遗传易感性、临床特征和治疗反应。

方法

本研究纳入了 260 名 AS 患者和 260 名匹配的健康献血者。采用聚合酶链反应扩增限制性片段长度多态性检测法确定 TNF-α-308 启动子多态性。

结果

群体遗传学分析显示,等位基因 A 和 G/A 基因型在 AS 患者(3.85%和 7.69%)和健康对照者(4.23%和 8.46%)中的发生率相同。与 G/G 基因型携带者相比,AS 患者 G/A 变异型的红细胞沉降率和血清 C 反应蛋白显著升高(87.06±49.40 vs. 55.53±42.99mm/h,P=.0126;54.95±27.77 vs. 34.36±36.13mg/dl,P=.0116),且他们总是表现出炎症性脊柱疼痛(70.00% vs. 43.33%,P=0.0214)和相对较轻的骶髂关节炎(65.00% vs. 41.67%,P=0.0431)。抗 TNF-α 治疗的良好反应者中,等位基因 G 和 G/G 基因型更为常见(96.55% vs. 73.53%,P=.0032;93.10% vs. 47.06%,P=.0015),而它们在预测 AS 常规药物治疗反应方面没有明显优势。

结论

本研究数据表明,TNF-α-308 多态性可能影响汉族人群 AS 的临床特征,而不是其易感性。

相似文献

1
TNF-α-308 polymorphism determines clinical manifestations and therapeutic response of ankylosing spondylitis in Han Chinese.TNF-α-308 多态性决定汉族强直性脊柱炎的临床表现和治疗反应。
Med Clin (Barc). 2017 Dec 20;149(12):517-522. doi: 10.1016/j.medcli.2017.04.023. Epub 2017 Jun 11.
2
Tumor necrosis factor-α promoter -308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-α and does not predict TNF inhibitor response.肿瘤坏死因子-α启动子-308/238多态性与强直性脊柱炎病情较轻的关联与血清肿瘤坏死因子-α无关,且无法预测肿瘤坏死因子抑制剂反应。
J Rheumatol. 2014 Aug;41(8):1675-82. doi: 10.3899/jrheum.131315. Epub 2014 Jul 15.
3
Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis.TNFRSF1A和TNFRSF1B基因多态性在肿瘤坏死因子受体超家族成员1A和1B基因多态性在人类白细胞抗原-B27阳性中国汉族强直性脊柱炎患者中对依那西普易感性、严重程度及治疗疗效的作用
Medicine (Baltimore). 2018 Aug;97(31):e11677. doi: 10.1097/MD.0000000000011677.
4
Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population.TNF 和 GRN 基因多态性与中国汉族人群强直性脊柱炎的相关性研究。
Rheumatol Int. 2018 Mar;38(3):481-487. doi: 10.1007/s00296-017-3899-7. Epub 2017 Dec 11.
5
TNF-α -857 and -1031 polymorphisms predict good therapeutic response to TNF-α blockers in Chinese Han patients with ankylosing spondylitis.TNF-α -857 和 -1031 多态性可预测中国汉族强直性脊柱炎患者对 TNF-α 阻滞剂的良好治疗反应。
Pharmacogenomics. 2012 Oct;13(13):1459-67. doi: 10.2217/pgs.12.133.
6
The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.肿瘤坏死因子(TNF)-α和TNF受体多态性在强直性脊柱炎易感性中的作用。
Clin Exp Rheumatol. 2009 Jul-Aug;27(4):645-8.
7
Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes.中国强直性脊柱炎患者外周血单个核细胞中,肿瘤坏死因子启动子区域-308G/A多态性与较高的脂多糖刺激的肿瘤坏死因子-α信使核糖核酸水平相关:与不同的A33/B58/Cw10单倍型有关。
Rheumatol Int. 2008 Dec;29(2):189-95. doi: 10.1007/s00296-008-0671-z. Epub 2008 Aug 22.
8
TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing spondylitis in Chinese Han population.肿瘤坏死因子-α和白细胞介素10基因多态性的相互作用增加了中国汉族人群患强直性脊柱炎的风险。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15204-9. eCollection 2015.
9
Tumor necrosis factor receptor-II nt587 polymorphism in Chinese Han patients with ankylosing spondylitis.中国汉族强直性脊柱炎患者肿瘤坏死因子受体-II nt587多态性
Genet Mol Res. 2014 Jul 7;13(3):5190-8. doi: 10.4238/2014.July.7.12.
10
Ankylosing spondylitis susceptibility and severity--contribution of TNF gene promoter polymorphisms at positions -238 and -308.强直性脊柱炎的易感性与严重程度——肿瘤坏死因子基因启动子-238和-308位点多态性的作用
Ann N Y Acad Sci. 2009 Sep;1173:581-8. doi: 10.1111/j.1749-6632.2009.04758.x.

引用本文的文献

1
Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis.肿瘤坏死因子α -308G/A基因多态性联合中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测强直性脊柱炎、类风湿关节炎和银屑病关节炎患者抗TNF-α治疗的疗效及安全性。
Front Pharmacol. 2022 Jan 21;12:811719. doi: 10.3389/fphar.2021.811719. eCollection 2021.
2
Screening of underlying genetic biomarkers for ankylosing spondylitis.强直性脊柱炎潜在遗传生物标志物的筛查。
Mol Med Rep. 2019 Jun;19(6):5263-5274. doi: 10.3892/mmr.2019.10188. Epub 2019 Apr 24.